Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Jun 11, 2020Leverages Dario's flexible AI-driven platform to facilitate rapid implementation and potential revenue in 2020DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has signed its first two remote patient monitoring (RPM) agreements. Remote...
- May 12, 2020Continued transformation to a software as a service (SaaS)-based membership model with recurring revenues and higher margin profile
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter 2020 and provided a corporate and commercial update....
-
May 6, 2020
DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings,...
- May 5, 2020Earnings Discussion and Business Update Scheduled for 8:30 am Eastern Time
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its first quarter ended March 31, 2020 financial...
-
May 4, 2020
DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) innovator, announced today that it has expanded its offering on its chronic care platform application to include...
- Apr 29, 2020Partnership with global telemedicine leader MediOrbis creates a social distancing compliant, complete care Dario solution
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in global digital therapeutics (DTx), announced today a new partnership with value-based telemedicine provider MediOrbis to expand Dario's existing...
-
Mar 26, 2020Chief Medical Officer and Head of Managed Markets to Report directly to Rick Anderson, President & General Manager North America
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Omar Manejwala, M.D to the newly created position of Chief Medical...
- Mar 25, 2020DarioHealth® Receives Endorsement from the Organization for the Review of Care & Health Applications (ORCHA)
DarioHealth Corp. (NASDAQ: DRIO), a global digital therapeutics (DTx) innovator, announced today an endorsement from the U.K. based ORCHA, highlighting the Company's Diabetes Management...
- Mar 24, 2020
DarioHealth Corp. (Nasdaq: DRIO) ("Dario") a pioneer in the global digital therapeutics market, announced today that it has entered into a partnership with Vitality Group, a global health and...
- Mar 17, 2020
DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a...
-
Mar 12, 2020Earnings Discussion and Business Update Scheduled for 8:30 am EDT
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its fourth quarter and year end 2019 results on Tuesday, March 17, and host a...
- Mar 5, 2020Yadin Shemmer & Adam K. Stern to serve until the 2020 Annual Meeting of Stockholders
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the company has appointed Yadin Shemmer and Adam K. Stern to serve as board members effective...
-
Feb 24, 2020
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as...
- Feb 19, 2020Patients Significantly Reduced Hypoglycemic and High Glycemic Events by 50% and 40%, respectively, over a Two-Year Period
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a pioneer in the global digital therapeutics market, today presented a new clinical study at the Advanced Technologies & Treatments for...
-
Jan 31, 2020
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that on January 30, 2020, Richard Anderson was granted a...
-
Jan 9, 2020Expertise Sharpens Dario's Focus on Execution and Expansion within the U.S. B2B Channel
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today the appointment of Richard Anderson as its President and...
-
Dec 20, 2019
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that it has closed on a private placement of convertible...
-
Dec 3, 2019DarioHealth Expands Retail Distribution Through Walmart.com
Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Walmart is the largest...
- Nov 25, 2019Dario Expands Membership Offering to a New Channel where Retailers are Visited by Millions of Consumers Each Year
Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), announced today that its online membership offering will now be available for purchase...
-
Nov 15, 2019- Based on data collected from active users, Dario proves digital interventions can play a key role in management of chronic conditions like diabetes
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting...
- Nov 14, 2019- DarioHealth CEO Joins Digital Health Industry Innovators panel in discussion on the need for clinical evidence
DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Dario's CEO, Erez Raphael, will be participating in a panel...
- Nov 12, 2019Action Urgent Care Selects DarioHealth's Blood Glucose Monitoring System™ to Extend Its Existing Digital Health Offering
Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of a Dario-powered digital diabetes program with Action Urgent Care. Action Urgent Care...
-
Oct 28, 2019
Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported financial and operational results for the third quarter ended September 30, 2019. Q3 2019 Revenues of $1.87...
-
Oct 22, 2019
DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, has appointed Dr. Abigail Hirsch to its Advisory Board where she will help guide...
-
Oct 17, 2019Earnings Discussion and Business Update Scheduled for 9:00 am EDT
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its third quarter 2019 results on Monday, October 28, and host a conference call the...